Glenmede Trust’s LivaNova LIVN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q4
Sell
-28
Closed -$1K 1783
2020
Q3
$1K Hold
28
﹤0.01% 2357
2020
Q2
$1K Buy
28
+16
+133% +$802 ﹤0.01% 2337
2020
Q1
$0 Hold
12
﹤0.01% 3039
2019
Q4
$0 Hold
12
﹤0.01% 3083
2019
Q3
$0 Buy
+12
New +$924 ﹤0.01% 3072
2019
Q2
Sell
-1,150
Closed -$111K 3129
2019
Q1
$111K Buy
+1,150
New +$107K ﹤0.01% 1371
2016
Q2
Sell
-121
Closed -$6K 2630
2016
Q1
$6K Hold
121
﹤0.01% 2171
2015
Q4
$6K Buy
+121
New +$7.34K ﹤0.01% 2213

Other funds holding LIVN

Glenmede Trust's LIVN Position: Q4 2020 in Review

Glenmede Trust sold out of LivaNova (LIVN) in Q4 2020, closing a stake of 28 shares — an estimated $1K sold.

Glenmede Trust first reported a position in LIVN in Q4 2015 and held it in 8 quarters. The position peaked at $111K in Q1 2019. 203 funds tracked by Wall St. Rank hold LIVN as of Q4 2020.

  • Glenmede Trust reported no remaining LivaNova position as of Q4 2020 after selling out during the quarter.
  • Glenmede Trust sold 28 LivaNova shares in Q4 2020, an estimated $1K.
  • Glenmede Trust first reported a position in LivaNova in Q4 2015 and held it in 8 quarters.
  • Glenmede Trust's LivaNova position peaked at $111K in Q1 2019.
  • 203 funds tracked by Wall St. Rank held LivaNova as of Q4 2020.

Based on Glenmede Trust's 13F filing for Q4 2020, filed 16 Feb 2021.